In one paragraphReview in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Vanessa TamasDepartment of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA 92093, USA.ORCID 0000-0002-9426-065X Erlinda R UlloaDepartment of Pediatrics, University of California Irvine School of Medicine, Irvine, CA 92697, USA.ORCID 0000-0002-0330-278X Monika KumaraswamyDepartment of Medicine, Division of Infectious Diseases, University of Texas Tyler, Tyler, TX 75799, USA.
Samira DaheshDivision of Host-Microbe Systems and Therapeutics, Center for Immunity, Infection and Inflammation, University of California San Diego School of Medicine, La Jolla, CA 92093, USA.ORCID 0009-0006-4451-2034 Raymond ZurichDivision of Host-Microbe Systems and Therapeutics, Center for Immunity, Infection and Inflammation, University of California San Diego School of Medicine, La Jolla, CA 92093, USA.
Victor NizetDivision of Host-Microbe Systems and Therapeutics, Center for Immunity, Infection and Inflammation, University of California San Diego School of Medicine, La Jolla, CA 92093, USA.ORCID 0000-0003-3847-0422 Alison CoadyDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0003-1871-5576 Funding
Surprising Efficacy of Discounted Antibiotics vs. MDR Gram-Negative Pathogens Occurring Through Innate Immune SensitizationR01AI145310 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KUMARASWAMY, MONIKA, NIZET, VICTOR · 2020 to 2023
$1.9MBeta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune ClearanceK08AI151253 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI ULLOA, ERLINDA ROSE · 2020 to 2024
$1.0MNIAID NIH HHS K08 AI151253NIAID NIH HHS R01 AI145310NIH HHS 1K22AI159917-01NIH HHS K08AI151253 (E.R.U.)NIH HHS UM1TR004927（E.R.U.）
6 · The paper itselfAbstract
Urinary tract infections (UTIs) are common in children and are predominantly caused by uropathogenic
Indexed as
antimicrobial resistanceEscherichia colipediatric infectionurinary tract infection
Identifiers
PMID41463786
PMCPMC12729730
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390